Replimune Group Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Replimune Group, Inc. (REPL) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Current Assets
Cash and Cash Equivalents0.110.070.580.400.480.170.13
Short-Term Investments0.370.350.440.290.290.000.00
Cash & Short-Term Investments0.480.420.580.400.480.170.13
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.010.010.000.000.000.000.00
Total Current Assets0.500.430.590.400.480.170.14
Non-Current Assets
Property, Plant & Equipment (Net)0.050.050.050.060.060.060.01
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.060.050.050.060.060.060.01
Total Assets0.550.490.650.460.540.230.15
Current Liabilities
Accounts Payable0.010.000.030.020.010.010.01
Short-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.040.020.020.010.010.000.00
Other Current Liabilities0.050.000.000.000.000.000.00
Total Current Liabilities0.060.040.030.020.010.010.01
Non-Current Liabilities
Long-Term Debt0.070.040.060.030.030.040.00
Other Non-Current Liabilities0.000.000.000.000.000.000.01
Total Non-Current Liabilities0.070.070.060.030.030.040.01
Total Liabilities0.140.110.090.050.040.050.02
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-0.95-0.70-0.48-0.31-0.19-0.11-0.06
Accumulated Other Comprehensive Income0.010.000.010.000.000.000.00
Additional Paid-in Capital1.361.071.030.720.690.300.20
Shares Outstanding0.080.060.060.050.000.000.00
Total Stockholders' Equity0.420.370.560.410.500.180.14
Total Liabilities & Equity0.550.490.650.460.540.230.15